Article 10 January, 2022

Hugh Sergeant’s outlook: Huge anomalies to exploit

Written by
Share

Print Friendly, PDF & Email

The good news for 2022, is that whilst there are clearly some very expensive equities to invest in, there are also very many good, value stocks, which one can invest in without diluting profits and cash flow growth potential. Last year should have been a Value and Recovery year. Instead it became another year when capital flowed into large cap growth companies which were therefore re-rated (again), led by the cheerleaders for this trade, the US mega-cap growth stocks.

“...[2021] was another frustrating year for me, but it sets up one of the biggest relative investment opportunities of my career.”

As a result, this was another frustrating year for me, but it sets up one of the biggest relative investment opportunities of my career. The key investment factors I exploit are at relative lows: Value is at a multi-generational low point, many recovery stocks are yet to see share price recovery, small caps have lagged badly recently especially in a global context.  These factors all provide a rich set of PVT anomalies in this segment of the market (including growth stocks, for example whilst Nasdaq hits all times highs over half of the constituents are down more than 50%), re-opening plays are back to relative lows, the best hedges on interest rate rises, namely banks, still trade on big discounts to book value, consumer cyclicals are depressed because of cost of living increases which are now overly discounted, China internet stocks trade on single digit earnings multiples, non-US stocks trade at record discounts to their US peers, with UK equities one of the most under-rated. I could go on.

So, there are huge anomalies for us to exploit, and perhaps we are now seeing the catalysts for these anomalies to generate alpha, with Omicron worries fading, and real yields turning less negative as Central Banks withdraw from artificially depressing bond yields. If the very recent swing in big picture dynamics continues, we are very well placed.

 

 

 

The information in this article has been prepared and issued by River and Mercantile Asset Management LLP (trading as “River and Mercantile” and “River and Mercantile Asset Management”) registered in England and Wales under Company No. OC317647, with its registered office at 30 Coleman Street, London EC2R 5AL.
River and Mercantile Asset Management LLP is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 453087) and is registered with the US Securities and Exchange Commission as an Investment Adviser under the Investment Advisers Act of 1940.
This article is directed at professional clients. The information in this article should not be relied on or form the basis of any investment decision.

ES R&M UK Recovery Fund

This fund enables investors to have targeted exposure to those companies we believe to have particularly strong potential to create value, following a period of depressed profits that could enable significant recovery.

Close up shot of runner's shoes

Latest perspectives

Hugh Sergeant’s outlook: Huge anomalies to exploit

Hugh Sergeant’s outlook: Huge anomalies ...

Article 10 January, 2022

Huge anomalies to exploit should lead us to a good position for 2022

3 min read

William Lough’s outlook: UK equities have been out-of-fashion but are well suited to the current environment

William Lough’s outlook: UK equities ...

Article 10 January, 2022

UK equities have been out-of-fashion but are well suited for the current environment, with low…

3 min read

Dan Hanbury’s outlook: Grounds for optimism

Dan Hanbury’s outlook: Grounds for ...

Article 10 January, 2022

As we enter 2022 with global equity markets at or around all-time highs, Dan Hanbury…

4 min read

James Sym’s outlook: Will 2022 be the year the industry stops playing at ESG, and starts doing it properly?

James Sym’s outlook: Will 2022 ...

Article 7 January, 2022

James Sym, Head of European Equities at River and Mercantile says that 2022 will be…

3 min read

Sign up to our newsletters

Stay ahead of the curve by receiving our newsletter containing current industry developments and insights.